These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27541275)

  • 41. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
    Prasad A; Ortiz-Lopez C; Khan A; Levin D; Kaye DM
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):264-73. PubMed ID: 26946253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.
    Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive factors for contrast-induced acute kidney injury in high-risk patients given N-acetylcysteine prophylaxis.
    Poh WY; Omar MS; Tan HP
    Ann Saudi Med; 2018; 38(4):269-276. PubMed ID: 30078025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contrast-induced acute kidney injury in cardiology].
    Genovesi E; Romanello M; De Caterina R
    G Ital Cardiol (Rome); 2016 Dec; 17(12):984-1000. PubMed ID: 28151503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contrast-Induced Acute Kidney Injury.
    McCullough PA; Choi JP; Feghali GA; Schussler JM; Stoler RM; Vallabahn RC; Mehta A
    J Am Coll Cardiol; 2016 Sep; 68(13):1465-1473. PubMed ID: 27659469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and Realities.
    Singh K; Bhargava V; Brar JE; Bhargava M; Kaushal R; Khullar D
    J Assoc Physicians India; 2021 Nov; 69(11):11-12. PubMed ID: 34781617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additional data supporting the use of statins to prevent contrast induced nephropathy.
    Pappy R; Abu-Fadel MS
    Int J Cardiol; 2011 Oct; 152(2):265-6. PubMed ID: 21872353
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
    Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
    Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast-Induced Acute Kidney Injury: An Update.
    Chalikias G; Drosos I; Tziakas DN
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):215-28. PubMed ID: 26780748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute Kidney Injury, AKI - Update 2018].
    Patschan D; Müller GA
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1094-1096. PubMed ID: 30060280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization.
    Khan SU; Khan MU; Rahman H; Khan MS; Riaz H; Novak M; Opoku-Asare I; Kaluski E
    Cardiovasc Revasc Med; 2019 Jan; 20(1):29-37. PubMed ID: 30757995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACP Journal Club: review: periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography.
    Bach RG
    Ann Intern Med; 2015 Feb; 162(4):JC4. PubMed ID: 25686191
    [No Abstract]   [Full Text] [Related]  

  • 58. Ascorbic acid for the prevention of contrast-induced acute kidney injury.
    McCullough PA; Akrawinthawong K
    J Am Coll Cardiol; 2013 Dec; 62(23):2176-7. PubMed ID: 23994411
    [No Abstract]   [Full Text] [Related]  

  • 59. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HMG-CoA enzyme inhibitors for prevention of contrast-induced nephropathy.
    Briasoulis A; Afonso L
    J Thromb Thrombolysis; 2014 Nov; 38(4):457-8. PubMed ID: 24832462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.